Get Live Data

Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. C4XD.L Share Price
  4. C4XD.L Share Regulatory News
  5. C4X Discovery signs potential $402mln deal

Pin to quick picksC4XD.L Regulatory News (C4XD)

C4XD.L Information
  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

C4X Discovery signs potential $402mln deal

28 Nov 2022 14:31

C4X Discovery Holdings PLC C4X Discovery signs potential $402mln deal 28.11.2022 / 15:30 CET/CEST The issuer is solely responsible for the content of this announcement.

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

28.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language:English
Company:C4X Discovery Holdings PLC
United States
ISIN:GB00BQQ2RV18
EQS News ID:1499599
 
End of NewsEQS News Service

1499599 28.11.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

12345
Date   Source Headline
28th Jun 20225:46 pmRNSAIM Rule 17 Schedule 2(g) Update
28th Apr 20227:00 amRNSHalf Year Results
19th Apr 20227:00 amRNSNotice of Results
28th Feb 20225:30 pmRNSExercise of Options, Issue of Equity and TVR
3rd Feb 20227:00 amRNSGrant of Options and Directors Dealing
1st Feb 20227:00 amRNSBlock listing Return
1st Feb 20227:00 amRNSBhavna Hunjan Appointed as Chief Business Officer
24th Jan 20224:09 pmRNSHolding(s) in Company
18th Jan 20223:07 pmRNSResult of AGM
14th Jan 20223:20 pmRNSHoldings in Company
21st Dec 20217:00 amRNSAppointment of Dr Cathy Tralau-Stewart as CSO
15th Dec 20217:00 amRNSAnnual Report and Notice of AGM
13th Dec 20216:11 pmRNSTotal Voting Rights
13th Dec 20217:00 amRNSFull Year Results
9th Dec 20217:00 amRNSNotice of Results
3rd Dec 202110:34 amRNSClive Dix wins Scrip Lifetime Achievement Award
2nd Dec 20217:01 amRNSClive Dix awarded Honorary Fellowship
2nd Dec 20217:00 amRNSBoard Change
26th Nov 202110:20 amRNSClive Dix wins OBN Special Recognition Award
19th Nov 20217:00 amRNSBoard Change
10th Nov 20215:01 pmRNSHolding(s) in Company
10th Nov 20214:58 pmRNSHolding(s) in Company
8th Nov 20214:33 pmRNSHolding(s) in Company
3rd Aug 20215:14 pmRNSTotal Voting Rights
1st Jul 202111:51 amRNSTotal Voting Rights
27th May 202110:04 amRNSExercise of Options
13th May 20212:49 pmRNSHolding(s) in Company
29th Apr 20217:00 amRNSInterim Results
22nd Apr 20214:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
22nd Apr 202111:31 amRNSNotice of Results
20th Apr 20217:00 amRNSBoard Appointment
12th Apr 20219:05 amRNSSecond Price Monitoring Extn
12th Apr 20219:00 amRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSSanofi Agreement
12th Mar 20217:00 amRNSHolding(s) in Company
11th Mar 20219:33 amRNSHolding(s) in Company
2nd Mar 202111:56 amRNSHolding(s) in Company
1st Mar 20214:26 pmRNSHolding(s) in Company
24th Feb 20212:03 pmRNSHolding(s) in Company
25th Jan 20219:37 amRNSHolding(s) in Company
19th Jan 20212:28 pmRNSResult of AGM
23rd Dec 20204:40 pmRNSSecond Price Monitoring Extn
23rd Dec 20204:36 pmRNSPrice Monitoring Extension
18th Dec 20209:12 amRNSPublication of 2020 Annual Report
17th Dec 20204:10 pmRNSHolding(s) in Company
14th Dec 20205:14 pmRNSGrant of options and Directors Dealing
10th Dec 20207:00 amRNSFull Year Results
9th Dec 20201:54 pmRNSHolding(s) in Company
8th Dec 20207:00 amRNSClive Dix named Interim Chair of Vaccine Taskforce
12345

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.